Most material SEC filings — August 18, 2026

TruGolf Holdings (Nevada corp, ~$3.2M market cap) agreed to acquire Polymath Research Inc. (Canadian fintech security token firm) via statutory amalgamation. Polymath shareholders receive 19.9% of Parent's Class A common stock plus Series C Convertible Preferred Stock valued collectively at $140M. Parent must raise concurrent financing of up to $5M (initial $3M tranche). Deal dated August 17, 2026; close expected by September 30, 2026.

Francisco Partners has entered into a definitive agreement to acquire Weave Communications for approximately $650 million in aggregate equity valuation. Weave stockholders will receive $7.40 per share in cash, representing a 34% premium to the closing price on August 17, 2026. The transaction is expected to close in Q4 2026, subject to stockholder approval and regulatory clearances; Weave will become private and remain headquartered in Lehi, Utah.

Cypherpunk Technologies acquired ~4,902 Bitmain Antminer Z15 Pro mining machines (4.2 GSol/s hashrate, ~18% of Zcash network) from Moria Mining LLC via asset purchase agreement dated August 17, 2026. Consideration: pre-funded warrant to Winklevoss Treasury Investments LLC for 43,290,042 common shares at $0.001 exercise price, implying $33.33M valuation at $0.77/share. Mining fleet deployed across three U.S. facilities (Barstow TX, Morristown TN, Fairview WV); hosting deposits totaling $782,668 transferred. Kevin Zhang appointed Head of Mining.

LUCIDITY, a 78-participant Phase 3 trial, met its FDA-agreed primary endpoint with avexitide demonstrating a 55% reduction in composite Level 2 and Level 3 hypoglycemic events versus placebo (p=0.000003). All secondary endpoints were also met. Avexitide has Breakthrough Therapy and Orphan Drug Designations; the company plans NDA submission by end of 2026, targeting potential 2027 commercial launch. No serious adverse events related to avexitide were reported; most adverse events were mild to moderate (diarrhea, injection site reactions).

On August 18, 2026, Metaplanet Holdings agreed to purchase 44.86M shares at $3.00/share (valued ~$134.6M at deal pricing), plus strategic preferred stock and warrants to purchase 381M common shares at escalating prices ($3–$33.50). The investment includes 2,100 Bitcoin (~$63.4M at $30.2K/BTC) and $2.5M cash. Metaplanet receives board control, a 24-month option to buy up to $210M in junior preferred stock, and the company will rebrand to 'Superplanet, Inc.' (ticker: SUPA). Major dilution: warrant exercise could add 381M shares; pre-funded warrants issued earlier (509.7K to Esports Now; 833.3K to Evo Fund) add further overhang.

Amylyx announced positive topline data from its Phase 3 LUCIDITY trial (N=78) showing avexitide 90 mg once daily achieved a statistically significant 55% reduction in composite Level 2 and Level 3 hypoglycemic events versus placebo (p=0.000003, rate ratio 0.45 [95% CI 0.32–0.63]), met all secondary endpoints, and was generally well-tolerated with no treatment-related serious adverse events. The company plans to submit an NDA to the FDA by end of 2026 and anticipates potential commercial launch in 2027 if approved.

Scott Pomeroy, who served as Chairman and CEO since December 2025, resigned effective August 17, 2026. Jeremy Schneiderman, CEO of subsidiary Drone Nerds LLC since 2014, was appointed interim CEO. Jonathan Ornstein was elected interim Chairman. Pomeroy received $138,461.54 in accrued PTO, $200,000 in unpaid bonuses, immediate vesting of 2,000,000 stock options, and 12 months of COBRA coverage. An Independent Special Committee investigation began June 25, 2026 regarding Pomeroy's conduct. The company filed Form 12b-25 delaying its 10-Q filing.

DataMeds AI (market cap ~$27.1M) raised $6.5M in June 2026 and reported Q2 2026 revenues of $1.779M (14% sequential growth), but posted a net operating loss of $18.363M in Q2 2026 vs. $6.672M in Q2 2025, driven by $8.881M debt extinguishment loss and other charges. The company executed a 1:50 reverse stock split in May 2026 to address NASDAQ delisting risk, completed a corporate rebranding to DataMeds AI with ticker change to MEDS, and is pursuing a pending multi-party transaction with Datavault AI, Scilex, EOS Technology, and HealthBridge to consolidate IP and launch a Health Lives Here app targeting GLP-1 patients via NFL Alumni Health partnership by September 2026. Shareholders representing ~49% of shares entered 90-day lock-up agreements.

Newbury Street II Acquisition Corp (SPAC, market value ~$180.2M) amended its underwriting agreement with BTIG, LLC effective upon closing the Fort Robotics business combination. Key change: deferred underwriting commission reduced to $2,000,000, payable from Trust Account at closing; if deal fails, underwriters forfeit commissions. Company also executing merger agreement with Fort Robotics, Inc., with $500M merger consideration in SPAC common stock; $31.25M PIPE financing secured; Transaction expected to close pending shareholder approvals and regulatory clearances.

Flash Sports & Media Holdings completed its February 17, 2026 merger with Innovative Production Group FZ, LLC, consolidating the Lanka Premier League operations. As of June 30, 2026, the company reported $266M total assets (including $122.8M goodwill and $132.6M intangibles from the merger), $191.9M stockholders' equity (vs. $45.2M deficit at year-end 2025), and $2.4M cash. Critically, $3.4M in LPL Season 6 franchise, sponsorship, and production fees were billed in advance but recorded as contract liabilities because Season 6 had not yet been delivered; these revenues are expected to be recognized in Q3 2026. Q2 continuing-operations revenue was only $0.1M; net loss was $8.0M ($0.91 per share).

Oncolytics received written FDA feedback supporting a two-part regulatory pathway for REO 033, a Phase 2 study of pelareorep in second-line RAS-mutant MSS metastatic colorectal cancer (n=60 Part A). FDA confirmed potential accelerated approval based on objective response rate, with progression-free survival supporting full approval. The company plans to launch Part B expansion upon positive Part A interim data and will pursue an End-of-Phase meeting with the FDA.

AIxCrypto announced a strategic shift away from its Digital Asset Treasury (DAT) strategy to focus on robotics operations and commercialization via RoboShare, an online robot rental marketplace. RoboShare completed its first paid commercial order on August 15, 2026—a deployment of six robots (one Master humanoid, four Aegis Pro quadrupeds, one Navi compact robot dog) for an event with Los Angeles-based entertainer DU$TY (7.1M Instagram followers). The company plans an orderly exit from digital assets and to expand RoboShare across a planned ten-city strategy, with Los Angeles as the first market.

Arxis completed its acquisition of Omnetics Connector Corporation for ~$770M enterprise value on August 18, 2026. Arxis issued 13,351,964 shares of Class A common stock (3.1% of total shares outstanding) to Omnetics shareholders, subject to lockup provisions. Combined with the MagCanica acquisition, the purchase multiple is ~12x FY27 estimated adjusted EBITDA. Omnetics, a Minneapolis-based designer/manufacturer of high-reliability connectors for defense, aerospace, and medical applications, will operate within Arxis' Electronic Components Segment.

Flotek entered a 10-year agreement on August 3, 2026, to supply power-generation equipment and PWRtek systems for a 400-megawatt project at Puerto Rico's Aguirre Power Plant. On August 17, 2026, the Financial Oversight and Management Board voted to direct PREPA to terminate the contract, and PREPA issued a work-stoppage directive. The company reaffirmed 2026 guidance ($340–$350M revenue; $47–$51M Adjusted EBITDA) excluding any PREPA contribution, having explicitly excluded this contract from prior guidance. No formal termination notice has been delivered to Flotek as of the filing date.

Elauwit Connection reported Q2 2026 contracted units of 42,687 (up 33% YoY, 16% QoQ) after signing ~5,900 units across 21 properties. Year-to-date, the company signed >10,000 units across 37 properties; two major REIT wins added 4,100 units across 14 properties. However, Q2 revenues fell 46% YoY to $2.9M (vs $5.3M in Q2 2025) due to timing of construction projects, and net loss expanded to $3.1M in Q2 2026 vs $0.9M in Q2 2025. The company targets >50,000 contracted units by year-end 2026 and expects construction/service revenue uptick in H2 2026.